Bill Of Health

APRIL 26, 2022

To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. A full video of the event is available below.

Biotechnology 52

Biotechnology Regulations Accountability Doctors 52

Bill Of Health

MARCH 23, 2023

By Enrique Santamaría Together with the Data Governance Act (DGA) and the General Data Protection Regulation (GDPR), the proposal for a Regulation on the European Health Data Space (EHDS) will most likely form the new regulatory and governance framework for the use of health data in the European Union. health data). If so, how?

Health Data 52

Health Data Regulations Biotechnology Pharmaceuticals 52

Bill Of Health

APRIL 19, 2023

Panelists discussed these topics during a recent webinar hosted by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. She discussed additional relevant neuroscience concepts, such as structural changes in gray matter and cortical thickness, and changes in personality and self-regulation.

Biotechnology 57

Biotechnology Rehabilitation Prevention Regulations 57

Bill Of Health

JANUARY 29, 2024

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

Biotechnology 142

Biotechnology Regulations Prevention Doctors 142

Bill Of Health

DECEMBER 8, 2023

It did not introduce unprecedented enablement principles, and, in practice, biotechnology genus claims, including antibody claims, were already limited. The other possibility is that Amgen will only affect the patentability of antibodies, which long received more lenient treatment than other biotechnologies.

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

Bill Of Health

JANUARY 18, 2024

She emphasizes the importance of Principle 5 , pertaining to “human rights duties relating to non-State actors,” thereby focusing more on State regulation of private actors than State coordination and cooperation with private actors.

Regulations 108

Regulations Prevention Accountability Pharmaceuticals 108

Bill Of Health

SEPTEMBER 21, 2021

These six students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. 2022) with research interests that include bioethics and national security, human enhancement, and the regulation of food, supplements, and exercise. Jack Becker is a law student (J.D.

Biotechnology 57

Biotechnology Regulations Pharmaceuticals Doctors 57

Bill Of Health

MARCH 1, 2024

Dr. Devenot is also an affiliated researcher with Project on Psychedelics Law and Regulation (POPLAR) at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Neşe Devenot, PhD is a Senior Lecturer in the University Writing Program at the Johns Hopkins University.

Accountability 108

Accountability Biotechnology Rehabilitation Regulations 108

Bill Of Health

OCTOBER 24, 2023

Despite more than a century-long existence, for instance, the World Health Organization’s (WHO’s) International Health Regulations only began to incorporate references to human rights in their text as recently as their 2005 iteration and even then engaged with the subject matter in broad strokes.

Biotechnology 88

Biotechnology Regulations Prevention Accountability 88

Bill Of Health

SEPTEMBER 22, 2022

These five students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. She has previously published articles on synthetic biology regulation and governance, end stage renal disease payment reform, and comparative analyses of learning disorder policy.

Biotechnology 52

Biotechnology Pharmaceuticals Medical Technology Regulations 52

Bill Of Health

AUGUST 18, 2021

These apps provide a window into some of the key issues in the world of digital health — including data privacy, data access, data ownership, bias, and the regulation of health technology. Direct-to-consumer (DTC) health apps, such as apps that manage our diet, fitness, and sleep, are becoming ubiquitous in our digital world.

Biotechnology 98

Biotechnology Regulations Accountability Health Data 98

Bill Of Health

NOVEMBER 9, 2022

Food and Drug Administration became the agency it is today and how it makes some of its toughest decisions regarding the regulation of potent drugs. On the other hand, the FDA also serves as a gatekeeper to drugs and can unduly limit drug accessibility by regulating too zealously. Sekeres tells a captivating story of how the U.S.

Regulations 104

Regulations Accountability Biotechnology Pharmaceuticals 104

Bill Of Health

OCTOBER 1, 2022

Since countries have sovereign rights over their biological resources , Indian companies enjoy easier access to and use of these biological resources for various commercial applications, including pharmaceuticals, cosmetics, and biotechnology. ” In other words, foreign investment up to at least 49% (less than majority) is encouraged.

Pharmaceuticals 52

Pharmaceuticals Biotechnology Regulations 52

Bill Of Health

APRIL 7, 2024

The FDA regulates food additives and “drugs and devices” but this latter designation is functionally split out into drugs, medical devices, and biologics (products derived from living sources). Notably, the GAO report was targeted at congressional committees to spur continued legislation and regulation in this space.

Regulations 44

Regulations Accountability Patient Experience Biotechnology 44

Bill Of Health

JANUARY 7, 2022

The legal and institutional regime aimed at preventing and controlling the spread of infectious diseases, grounded on the International Health Regulations (IHR) was heavily criticized. The COVID-19 pandemic has raised unprecedented challenges for the global health framework and its long-term consequences are not yet in full sight.

Biotechnology 57

Biotechnology Prevention Regulations 57

Health Advances

MARCH 8, 2023

Success of future AI in healthcare hinges on incorporating considerations for algorithmic bias, patient privacy, and safety into model development, collaborating with regulators and policymakers, and educating patients on AI use in healthcare. With innovation, there comes a lag in necessary regulation and policy changes. Eisenstein, M.

Healthcare 52

Healthcare Biotechnology Regulations Doctors 52

Bill Of Health

APRIL 18, 2023

This sets the Convention apart from the EU’s AI Act, which focuses on regulating the development phase, and only stipulates strict rules for “high-risk” AI medical devices. It establishes these as enforceable rights — filling an often-criticized gap of other AI regulations.

Regulations 57

Regulations Doctors Accountability Biotechnology 57

Bill Of Health

JANUARY 23, 2023

Individual countries and laboratories have instituted preventive self-regulation , however these vary country-by-country. Taiwan has engaged with international partners to perform “Joint External Evaluations” and developed national legislature for regulating high containment laboratories. Other countries have not been as diligent.

Prevention 113

Prevention Regulations Biotechnology 113

Bill Of Health

MAY 8, 2023

Daar explains how regulations protecting embryos could potentially restrict IVF, focusing on issues around embryo discard, cryopreservation, preimplantation genetic testing, and selective reduction. Judith Daar on the future of IVF in a post- Dobbs U.S.

Regulations 93

Regulations Doctors Prevention Biotechnology 93

Bill Of Health

NOVEMBER 10, 2022

Balancing Regulation, Innovation and Ethics : Examining the challenges of balancing the competing concerns and trade-offs that arise in real-world settings, most obviously in hospitals and the physician-patient relations.

Medical Technology 85

Medical Technology Regulations Prevention Healthcare 85

Health Advances

SEPTEMBER 15, 2020

Investors in Hong Kong who are closer to China can better understand the equity story of Chinese biotechnology companies. HKEX looks forward to continue working closely with Mainland exchanges and regulators to create more effective and efficient fundraising opportunities for biotech companies, such as A+H and Red chip+STAR board listings.”.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences Healthcare 98

American College of Healthcare Sciences

NOVEMBER 18, 2021

CFR – code of federal regulations 21. Electronic Code of Federal Regulations. 9] Electronic Code of Federal Regulation. Medicinal and Aromatic Plant Science and Biotechnology, 3(1):90-93. [16] Electronic Code of Federal Regulation. Electronic Code of Federal Regulation. 17(Suppl), 1979. [2] 17] [link].

Regulations 68

Regulations Biotechnology Healthcare Primary Care 68

Bill Of Health

DECEMBER 14, 2022

Moreover, while many scientists, regulators , and members of the public have called for societal discourse or consensus related to individual reproductive genetic innovation techniques, these calls rarely include an explanation as to how these discourses would be conducted.

Clinical Practice 82

Clinical Practice Regulations Prevention Biotechnology 82

Bill Of Health

NOVEMBER 17, 2023

By Adithi Iyer Last month, President Biden signed an Executive Order mobilizing an all-hands-on-deck approach to the cross-sector regulation of artificial intelligence (AI). Some questions that are less than an eventuality: is now too soon for sweeping AI regulations?

Biotechnology 99

Biotechnology Regulations Patient Safety Health Data 99

Bill Of Health

APRIL 4, 2024

Cross-sectoral EU laws First and foremost, the product as a whole must comply with the Medical Device Regulation (MDR) and the specific norms incorporated therein, as well as with GDPR requirements and ESG considerations, just to name a few. AI regulation has, for the most part, been sectoral rather than cross-sectoral.

Regulations 113

Regulations Accountability Health Data Patient Safety 113

Bill Of Health

MARCH 8, 2023

He and his collaborators had “ forged ethical review documents and misled doctors into unknowingly implanting gene-edited embryos into two women ” in deliberate violation of national regulations on biomedical research and medical ethics. He Jiankui’s Controversial Comeback Fast forward to the present.

Regulations 100

Regulations Doctors Prevention Biotechnology 100

Bill Of Health

APRIL 6, 2022

This delays the time before a generic drug or biosimilar can get approved, by blocking regulators from using the first applicant’s clinical data for the approval of competitors’ versions. Many countries provide a type of monopoly protection for new drug approvals called “ data exclusivity.”

Pharmaceuticals 123

Pharmaceuticals Prevention Regulations Biotechnology 123

Bill Of Health

SEPTEMBER 15, 2023

The Bill also introduces the right for employees, or agency workers post-qualifying period, in a “qualifying relationship with a person receiving fertility treatment” to take time off for appointments.

Medical Practitioners 57

Medical Practitioners Nursing Primary Care Regulations 57

Bill Of Health

JUNE 12, 2023

By Matthew Chun The U.S. Food and Drug Administration (FDA), in fulfilling its task of ensuring that drugs are safe and effective, has recently turned its attention to the growing use of artificial intelligence (AI) and machine learning (ML) in drug development.

Pharmaceuticals 104

Pharmaceuticals Accountability Biotechnology Regulations 104

Bill Of Health

DECEMBER 1, 2023

By Adithi Iyer As the provision of human tissue leaves the research realm and becomes a bona fide consumer transaction , our legal responses to these developments will be most effective when we know what we want to protect, and how. Perhaps the most famous discussion around tissue “donation” comes from the story of Henrietta Lacks and her family.

Prevention 62

Prevention Biotechnology Regulations 62

Bill Of Health

JANUARY 24, 2024

By Adithi Iyer The legal world is atwitter with the developing artificial intelligence (“AI”) copyright cage match between The New York Times and OpenAI. The Times filed its complaint in Manhattan Federal District Court on December 27 accusing OpenAI of unlawfully using its (copyrighted and paywalled) articles to train ChatGPT.

Pharmaceuticals 51

Pharmaceuticals Biotechnology Regulations Healthcare 51

Bill Of Health

OCTOBER 10, 2022

Business is bustling for biotechnology and biomanufacturing. On September 12, 2022, President Biden signed an executive order , launching a “whole-of-government approach to advance biotechnology and biomanufacturing.” Biotechnology regulation. By Matthew Chun. Bio-related data set development and management.

Biotechnology 98

Biotechnology Pharmaceuticals Regulations Prevention 98

Bill Of Health

DECEMBER 20, 2023

AbbVie’s position is representative: “Genus claims with functional limitations promote the progress of science…[they] are especially important in chemistry, pharmaceuticals, and biotechnology, where breakthrough innovations invariably require very significant investments of time and money.” The Alliance of U.S.

Pharmaceuticals 62

Pharmaceuticals Biotechnology Prevention Regulations 62

Bill Of Health

AUGUST 29, 2022

IBM and Google) to biotechnology (e.g., As noted above, the Open COVID Pledge , as well as vaccine availability programs by Pfizer, Merck and others , are all tied to the WHO’s determination of pandemic status, as are the commitments of the 196 countries bound by the WHO’s International Health Regulations.

Biotechnology 145

Biotechnology Prevention Pharmaceuticals Regulations 145

Bill Of Health

SEPTEMBER 22, 2021

The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts. Though the Workshop is typically open to the public, it is not currently, due to the COVID-19 pandemic.

Biotechnology 82

Biotechnology Regulations Hospitals 82

Bill Of Health

SEPTEMBER 28, 2023

Moreover, the NASDAQ Biotechnology Index increased by 374% from 1995 to 2000. For instance, public and private investment significantly increased —the average NIH budget was $55 billion higher between 1996 and 2000 compared to between 1990 and 1994.

Pharmaceuticals 82

Pharmaceuticals Biotechnology Integration Public Health services 82

Bill Of Health

OCTOBER 15, 2021

The COVID-19 pandemic has laid bare the lack of regulation for the sharing of intellectual property (IP) and technology needed for an effective and equitable response to the crisis. The COVID-19 pandemic demonstrates that it is difficult to regulate the open sharing of IP/know-how and technology while a global health emergency is unfolding.

Pharmaceuticals 128

Pharmaceuticals Quality Assurance Health Technology Regulations 128